A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis

NCT02693210 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Cyclophosphamide
DRUG: Methotrexate
OTHER: Placebo Cyclophosphamide
OTHER: Placebo Methotrexate
OTHER: Placebo Rituximab
DRUG: Rituximab

Sponsor

Hoffmann-La Roche